Page last updated: 2024-12-05

n-methylbenzylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-methylbenzylamine: precursor of carcinogen benzylmethylnitrosamine; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7669
CHEMBL ID1338
SCHEMBL ID2271
MeSH IDM0095229

Synonyms (87)

Synonym
benzyl(methyl)amine
n-methyl(phenyl)methanamine
n-benzyl-n-methylamine
benzylmethylamine
benzylamine, n-methyl
methylbenzylamine
n-methy-n-benzylamine
nsc-8059
n-methylbenzylamine
benzylamine, n-methyl-
n-benzylmethylamine
benzenemethanamine, n-methyl-
103-67-3
nsc8059
SDCCGMLS-0066901.P001
SPECTRUM_001362
SPECTRUM4_001764
n-methyl-1-phenyl-methanamine
n-methyl-1-phenylmethanamine
inchi=1/c8h11n/c1-9-7-8-5-3-2-4-6-8/h2-6,9h,7h2,1h
n-benzylmethylamine, 97%
NCGC00166047-01
SPECTRUM5_000347
KBIOSS_001842
KBIOGR_002247
KBIO2_006978
KBIO2_001842
KBIO2_004410
CHEMBL1338
omega-methylaminotoluene
M0164
AKOS000119094
ec 203-133-4
ai3-26793
nsc 8059
unii-7kn7f4x49e
7kn7f4x49e ,
einecs 203-133-4
MLS004773900
smr000112361
FT-0631560
benzyl-methyl-amine
AR1001
SCHEMBL2271
n-benzyl methylamine
benzyl methylamine
methyl(phenylmethyl)amine
n-benzyl-n-methyl-amine
n-methylbenzyl amine
n-methyl benzyl amine
n-methylbenzenemethanamine
n-methyl-benzenemethanamine
racemic methylbenzyl amine
methyl-benzyl amine
n-methyl-benzyl amine
n-methyl -benzylamine
benzyl-methylamine
(-)-methylbenzylamine
n-methyl-n-benzylamine
benzyl methyl amine
n-methyl-n-(phenylmethyl)amine
n-methyl-n-benzyl amine
methyl benzylamine
hnmebzl
n-benzyl methyl amine
n-benzylmethanamine
n-benzyl-methylamine
n-methyl benzylamine
methylbezylamine
n-methyl-benzylamine
n-benzyl-methyl amine
DTXSID9048439
STR02536
W-108843
CS-W007426
F2190-0316
mfcd00008289
benzylmethyl-d3-amine
Q23978278
BRD-K44558320-003-01-7
STL196319
HY-W007426
(+)-2-methylbutylp-aminocinnamate
Z57327124
EN300-18191
n-(phenylmethyl)methylamine
methylbenzylamine, n-

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Pharmacokinetic investigations have shown the drug to be highly bound to blood proteins, mainly serum albumin, and to have a low brain uptake, explaining its lack of sedative effects."( Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist.
Carrupt, PA; Jolliet, P; Morin, C; Morin, D; Pagliara, A; Rihoux, JP; Testa, B; Tillement, JP; Urien, S, 1998
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID643449Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by ten-fold serial dilution method2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Design, synthesis, and evaluation of thiol-activated sources of sulfur dioxide (SO₂) as antimycobacterial agents.
AID26548compound was evaluated for reverse occurs for the rate constant(log K-1) at pH 7.41998Journal of medicinal chemistry, Mar-12, Volume: 41, Issue:6
Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist.
AID643450Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition at 100 ug/ml by ten-fold serial dilution method2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Design, synthesis, and evaluation of thiol-activated sources of sulfur dioxide (SO₂) as antimycobacterial agents.
AID26563compound was evaluated for rate constant of transfer (log K1) at pH 7.41998Journal of medicinal chemistry, Mar-12, Volume: 41, Issue:6
Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist.
AID26287Partition coefficient (logD3.0)1998Journal of medicinal chemistry, Mar-12, Volume: 41, Issue:6
Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (45.45)18.7374
1990's3 (13.64)18.2507
2000's5 (22.73)29.6817
2010's4 (18.18)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.55 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index71.75 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (48.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]